Search | Search by Center | Search by Source | Keywords in Title
Hou JK, Kramer JR, Richardson P, Sansgiry S, El-Serag HB. Tuberculosis and Hepatitis B Reactivation are Rare after Treatment with Tumor Necrosis Factor Antagonist Therapy among Patients with Inflammatory Bowel Disease. Poster session presented at: Digestive Disease Week Annual Conference; 2015 May 16; Washington, DC.